结构性心脏病患者的左束枝节奏:个性化心脏再同步疗法
Jacqueline Joza1, Justin Luermans2, Vartan Mardigyan3
1Department of Medicine, McGill University Health Centre, Montreal, Canada.
概括
左束枝节奏 (LBBP) 为心力衰竭的心脏再同步治疗 (CRT) 提供了一种新的方法. 个性化策略对于最佳结果至关重要,考虑到个体传导疾病.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 心脏衰竭管理的管理
背景情况:
- 双管节律是心力衰竭中心脏再同步治疗 (CRT) 的标准.
- 左束枝节奏 (LBBP) 是CRT的一个新兴的生理替代方案.
- 在患有复杂导电性疾病的心力衰竭患者中,LBBP的有效性尚未完全确定.
研究的目的:
- 为将LBBP整合到CRT提供一个框架.
- 以指导基于导电基板的个性化方法.
- 为了优化心力衰竭患者的治疗效益.
主要方法:
- 审查当前的文献和临床实践指南.
- 对LBBP的植入前,过程内和植入后评估策略的分析.
- 开发用于置和治疗选择的实践指南.
主要成果:
- 在CRT中,LBBP提供了一个生理学上的替代方案,可以替代双心室节奏.
- 考虑导电基板的个性化方法对于LBBP的成功至关重要.
- 关于何时单独使用LBBP,用冠状动脉鼻引领或常规双心脏节奏的指导.
结论:
- LBBP是一个有前途的CRT选项,但需要采取量身定制的方法.
- 对传导性疾病的个性化评估是最大化LBBP益处的关键.
- 该框架支持心力衰竭中CRT的知情决策.
相关概念视频
Dysrhythmias IV: Characteristics of Bradyarrhythmias
120
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
120
Cardiomyopathy III: Hypertrophic Cardiomyopathy
52
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
52
Electrophysiology of Normal Cardiac Rhythm
6.8K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
6.8K
Cardiomyopathy II: Dilated Cardiomyopathy
23
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
23
Heart Failure Drugs: Inotropic Agents
728
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
728
Dysrhythmias VI: Management of Dysrhythmias
107
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
107


